Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications-authors’ reply
Open Access
- 14 April 2020
- journal article
- letter
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 51 (9), 916-917
- https://doi.org/10.1111/apt.15699
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medicationsAlimentary Pharmacology & Therapeutics, 2020
- Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st CenturyClinical Gastroenterology and Hepatology, 2020
- Pregnant women with IBD are more likely to be adherent to biologic therapies than other medicationsAlimentary Pharmacology & Therapeutics, 2019
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesThe Lancet, 2017
- Preconception Care Reduces Relapse of Inflammatory Bowel Disease During PregnancyClinical Gastroenterology and Hepatology, 2016
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in PregnancyGastroenterology, 2016
- Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2016
- Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views.Journal of Crohn's and Colitis, 2013
- Development and Validation of an Administrative Case Definition for Inflammatory Bowel DiseasesCanadian Journal of Gastroenterology, 2012
- Pregnancy and IBD treatment: This challenging interplay from a patients' perspectiveJournal of Crohn's and Colitis, 2010